GRI BIOPAR |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.41 USD | -4.43% |
|
-4.65% | -93.88% |
| 04-16 | GRI Bio Receives South Korea Patent for Liver Inflammatory Condition Treatments | MT |
| 2023 | Vallon Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 2.570 | 3.290 | 3.123 |
| Spread/Res. | -84.05% | -87.54% | -86.87% |
| Spread/Supp. | +17.14% | +17.14% | +36.21% |
| Support | 0.3500 | 0.3500 | 0.3010 |
- Stock Market
- Equities
- GRI Stock
- Charts GRI BIOPAR
